急性肠系膜缺血:血管内介入减少住院时间且具成本效益
基于美国全国住院患者样本2004至2014年急性肠系膜缺血患者的分析,3833例(37%)为男性,平均年龄69岁(范围18-98岁);4543例(44%)接受血管内介入(ENDO),5839例(56%)接受开放手术(OPEN)。血管内介入与较低死亡率(12.3% vs 33.1%,P<.0001)和较低平均住院费用(41,615美元 vs 60,286美元,P<.0001)相关;倾向调整后开放手术与较高死亡率(比值比3.0,97.5%CI 2.2-4.1)及较高费用(平均9,196美元,97.5%CI 3,797-14,595美元)仍显著相关。
要点
- 血管内介入组住院死亡率12.3%,开放手术组33.1%,P<.0001。
- 血管内介入组平均住院费用41,615美元,开放手术组60,286美元,P<.0001。
- 倾向调整后开放手术与较高死亡率(比值比3.0,97.5%CI 2.2-4.1)和较高费用(平均9,196美元)相关。
核心结论
- 血管内介入治疗急性肠系膜缺血与开放手术相比,住院死亡率约为后者的三分之一(比值比3.0,97.5%CI 2.2-4.1),每例住院节省费用9,196美元(97.5%CI 3,797-14,595美元),出院存活的风险比为2.27(97.5%CI 2.00-2.58),且较少发生急性肾损伤和出院回家。
- 尽管全国范围内血管内介入使用率持续上升,但在急性肠系膜缺血治疗中仍未超过开放手术血运重建。
研究设计与样本
- 基于美国全国住院患者样本(National Inpatient Sample)2004至2014年因急性肠系膜缺血入院并接受开放手术血运重建(OPEN)或血管内介入(ENDO)的所有患者。
- 共识别10,381例出院记录,其中3833例(37%;97.5%CI 35%-39%)为男性,平均年龄69岁(范围18-98岁);4543例(44%;97.5%CI 41%-47%)接受ENDO,5839例(56%;97.5%CI 53%-59%)接受OPEN。
- 主要终点为住院时间和住院费用;次要终点包括急性肾损伤、住院死亡率和常规出院。
主要发现
- ENDO组中度至重度Charlson合并症指数比例为28%(97.5%CI 24%-31%),OPEN组为14%(97.5%CI 11%-16%),P<.0001。
- ENDO组住院死亡率为12.3%(97.5%CI 9.8%-14.8%),OPEN组为33.1%(97.5%CI 29.9%-36.2%),P<.0001。
- ENDO组平均住院费用为41,615美元(97.5%CI 38,663-44,567美元),OPEN组为60,286美元(97.5%CI 56,736-63,836美元),P<.0001。
- 倾向调整逻辑回归分析后,OPEN与较高死亡率仍显著相关(比值比3.0;97.5%CI 2.2-4.1),并与较高费用相关(平均9,196美元;97.5%CI 3,797-14,595美元)。
- OPEN组急性肾损伤风险较高(P<.0001),出院至专业护理机构而非回家的风险较高(P<.0001)。
关键数值与推荐
- ENDO组住院死亡率12.3%(97.5%CI 9.8%-14.8%) vs OPEN组33.1%(97.5%CI 29.9%-36.2%),P<.0001。
- ENDO组平均住院费用41,615美元(97.5%CI 38,663-44,567美元) vs OPEN组60,286美元(97.5%CI 56,736-63,836美元),P<.0001。
- 倾向调整后OPEN vs ENDO死亡比值比3.0(97.5%CI 2.2-4.1);费用平均差9,196美元(97.5%CI 3,797-14,595美元)。
- 出院存活风险比2.27(97.5%CI 2.00-2.58),ENDO组高于OPEN组。
临床怎么用
- 原文结论未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Acute mesenteric ischemia (AMI) continues to be one of the most devastating diagnoses requiring emergent vascular intervention. There is a national trend toward increased use of endovascular procedures, with improved survival for the treatment of these patients. Our aim was to evaluate whether this trend has changed the treatment of AMI and the subsequent impact on length of hospitalization and hospitalization costs. METHODS: We identified all patients admitted for AMI from the National Inpatient Sample from 2004 to 2014 who received open surgical revascularization (OPEN) or an endovascular intervention (ENDO). Primary end points included length of hospital stay and cost of hospitalization. Our secondary end points included acute kidney injury (AKI), in-hospital mortality, and routine discharge. RESULTS: Among 10,381 discharges identified in the data set, 3833 (37%; 97.5% confidence interval [CI], 35%-39%) were male patients with a mean age of 69 years (range, 18-98 years); 4543 (44%; 97.5% CI, 41%-47%) patients were treated ENDO, and 5839 (56%; 97.5% CI, 53%-59%) patients were treated OPEN. Although a higher proportion of patients in the ENDO group (28%; 97.5% CI, 24%-31%) vs the OPEN group (14%; 97.5% CI, 11%-16%) had a moderate to severe Charlson Comorbidity Index (P < .0001), ENDO was associated with a lower mortality rate (12.3% [97.5% CI, 9.8%-14.8%] vs 33.1% [97.5% CI, 29.9%-36.2%]; P < .0001) and a lower mean hospitalization cost ($41,615 [97.5% CI, $38,663-$44,567] vs $60,286 [97.5% CI, $56,736-$63,836]; P < .0001). After propensity-adjusted logistic regression analysis, OPEN retained a significant association with higher mortality than ENDO (odds ratio, 3.0; 97.5% CI, 2.2-4.1) and with higher costs (mean, $9196; 97.5% CI, $3797-$14,595). Patients in the OPEN group had higher risk for AKI (P < .0001) and discharge to a skilled nursing facility (P < .0001) rather than home. CONCLUSIONS: Although the rate of ENDO continues to rise nationally, it still has not surpassed OPEN revascularization in the face of AMI. Patients treated endovascularly demonstrated one-third the rate of in-hospital mortality (odds ratio, 3.0; 97.5% CI, 2.2-4.1), an increased hazard ratio for discharge alive (hazard ratio, 2.27; 97.5% CI, 2.00-2.58), and a cost saving of $9196 (97.5% CI, $3797-$14,595) per hospitalization. Furthermore, they were less likely to develop AKI and to be discharged home after hospitalization.
引用
- Erben Y, Protack CD, Jean RA, et al. Endovascular interventions decrease length of hospitalization and are cost-effective in acute mesenteric ischemia. J Vasc Surg. 2018. PMID: 29459015. doi:10.1016/j.jvs.2017.11.078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。